$COGTLocated a potential "abc" wave after a 5 wave impulse. Price also near a support level. Looking for bullish volume to help price retrace to 9.74.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.47 USD
−255.86 M USD
0.00 USD
95.39 M
About Cogent Biosciences, Inc.
Sector
Industry
CEO
Andrew R. Robbins
Website
Headquarters
Waltham
Founded
2014
FIGI
BBG007DHZQR7
Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. The company was founded by Charles Wilson and Dario Campana in March 2014 and is headquartered in Waltham, MA.
Watching: COGTXYZ is now on my watchlist for tomorrow. I got a setup signal on my custom indicator (yellow dot). Looking to enter if the stock can manage to close above the last candle highs with a s stop-loss below and a price target above. “Don’t scare yourself out of a trade by going into lower time frames.”
COGT a botechology stock with a great uptrend SHORTCOGY a biotechonology stock is doing what others
in the sector typically do in their performance when they
ignore general market dynamics and often hold up in recessions.
COGT has 4Xed since May earnings so ALPHA is high.
Right now the RSI is down trending so showing bearish divergence.
Additi
COGT going upCOGT has been trading in the range during 7 months.
Being close to the support it gives an opportunity to buy it with a tight stop-loss just below the support level.
Potential profit:
1) 40-50% if bought close to the support at 8.40 and sold as close as possible to resistance at 13.28.
But I would n
$COGT : Potential Run UpThis idea is based solely off technicals.
Multiple S/R touches, decent volume, macd looks good on 4h chart
This could be a good play, I will keep my eye on it tomorrow at the open, if it dips below $8.49 ish I will take a position. If there is a hard dump below my stop loss point, I will not be en
COGT, Technical entry , low float Unum Therapeutics Inc., a biopharmaceutical company, focuses on developing a pipeline of novel therapies to treat cancer patients.
This is a technical based entry , product is ranging so I will set my target at a realistic resistance area .
I do like some of their fundamental metrics too. Primaril
COGT D1: BEST Level to BUY/HOLD 200%+ gains(SL/TP)(STOCKS)Why get subbed to me on Tradingview?
-TOP author on TradingView
-15+ years experience in markets
-Professional chart break downs
-Supply/Demand Zones
-TD9 counts / combo review
-Key S/R levels
-No junk on my charts
-Frequent updates
-Covering FX/crypto/US stocks
-24/7 uptime so constant updates
COGT - A Rebound in the MakingHistorically this is a stock that can move up and down with big swings. Right now we're in a valley, but I'm fairly positive, given enough time, this will bounce back. I'm holding even though I'm down. I just hope the valley doesn't get much deeper because it's getting harder to see the next mountai
COGT- Flag formation & huge insider buying Long from $4.54 to $6COGT seems forming a flag formation. On the other side it has a tones of insider buying. Executive Chairman of the Board picked up around 20 million
worth of shares just week ago. There are some other insider buying as well. Overall it seems very interesting Long set up.
* Trade Criteria *
Date
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of COGT is 4.58 USD — it has increased by 7.51% in the past 24 hours. Watch Cogent Biosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cogent Biosciences, Inc. stocks are traded under the ticker COGT.
COGT stock has risen by 0.66% compared to the previous week, the month change is a −37.94% fall, over the last year Cogent Biosciences, Inc. has showed a −30.08% decrease.
We've gathered analysts' opinions on Cogent Biosciences, Inc. future price: according to them, COGT price has a max estimate of 24.00 USD and a min estimate of 8.00 USD. Watch COGT chart and read a more detailed Cogent Biosciences, Inc. stock forecast: see what analysts think of Cogent Biosciences, Inc. and suggest that you do with its stocks.
COGT reached its all-time high on Aug 7, 2018 with the price of 70.64 USD, and its all-time low was 1.18 USD and was reached on Apr 9, 2020. View more price dynamics on COGT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
COGT stock is 8.43% volatile and has beta coefficient of 0.97. Track Cogent Biosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Cogent Biosciences, Inc. there?
Today Cogent Biosciences, Inc. has the market capitalization of 521.43 M, it has decreased by −20.90% over the last week.
Yes, you can track Cogent Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Cogent Biosciences, Inc. is going to release the next earnings report on May 13, 2025. Keep track of upcoming events with our Earnings Calendar.
COGT earnings for the last quarter are −0.61 USD per share, whereas the estimation was −0.60 USD resulting in a −1.93% surprise. The estimated earnings for the next quarter are −0.58 USD per share. See more details about Cogent Biosciences, Inc. earnings.
Cogent Biosciences, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
COGT net income for the last quarter is −67.93 M USD, while the quarter before that showed −70.63 M USD of net income which accounts for 3.83% change. Track more Cogent Biosciences, Inc. financial stats to get the full picture.
No, COGT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 15, 2025, the company has 205 employees. See our rating of the largest employees — is Cogent Biosciences, Inc. on this list?
Like other stocks, COGT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cogent Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cogent Biosciences, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cogent Biosciences, Inc. stock shows the strong sell signal. See more of Cogent Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.